rs650439
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004795.4(KL):c.2701+22T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.841 in 1,609,134 control chromosomes in the GnomAD database, including 570,873 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.81 ( 50275 hom., cov: 31)
Exomes 𝑓: 0.84 ( 520598 hom. )
Consequence
KL
NM_004795.4 intron
NM_004795.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.97
Genes affected
KL (HGNC:6344): (klotho) This gene encodes a type-I membrane protein that is related to beta-glucosidases. Reduced production of this protein has been observed in patients with chronic renal failure (CRF), and this may be one of the factors underlying the degenerative processes (e.g., arteriosclerosis, osteoporosis, and skin atrophy) seen in CRF. Also, mutations within this protein have been associated with ageing and bone loss. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 13-33061802-T-A is Benign according to our data. Variant chr13-33061802-T-A is described in ClinVar as [Benign]. Clinvar id is 1222763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KL | NM_004795.4 | c.2701+22T>A | intron_variant | ENST00000380099.4 | NP_004786.2 | |||
KL | XM_006719895.3 | c.1780+22T>A | intron_variant | XP_006719958.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KL | ENST00000380099.4 | c.2701+22T>A | intron_variant | 1 | NM_004795.4 | ENSP00000369442 | P1 | |||
KL | ENST00000487852.1 | n.2759+22T>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.809 AC: 123066AN: 152040Hom.: 50237 Cov.: 31
GnomAD3 genomes
AF:
AC:
123066
AN:
152040
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.819 AC: 200289AN: 244550Hom.: 82822 AF XY: 0.823 AC XY: 109260AN XY: 132686
GnomAD3 exomes
AF:
AC:
200289
AN:
244550
Hom.:
AF XY:
AC XY:
109260
AN XY:
132686
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.844 AC: 1229547AN: 1456976Hom.: 520598 Cov.: 38 AF XY: 0.844 AC XY: 611919AN XY: 724878
GnomAD4 exome
AF:
AC:
1229547
AN:
1456976
Hom.:
Cov.:
38
AF XY:
AC XY:
611919
AN XY:
724878
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.809 AC: 123154AN: 152158Hom.: 50275 Cov.: 31 AF XY: 0.809 AC XY: 60155AN XY: 74380
GnomAD4 genome
AF:
AC:
123154
AN:
152158
Hom.:
Cov.:
31
AF XY:
AC XY:
60155
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2479
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Tumoral calcinosis, hyperphosphatemic, familial, 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at